Gavi [to 27 February 2016]
http://www.gavialliance.org/library/news/press-releases/

.
26 February 2016
Positive impact of Advance Market Commitment highlighted in report
Innovative financing mechanism helping pneumococcal vaccines reach poorest children in record time.
Geneva,– Children in the world’s poorest countries are being protected against the leading cause of pneumonia more quickly than ever thanks in part to the influence of the pilot Advance Market Commitment (AMC) for pneumococcal vaccines, an independent evaluation report published today confirms.

The AMC Outcomes and Impact Evaluation examined the role of the AMC in the successful introduction of the pneumococcal vaccine into the routine immunisation programmes of more than 50 developing countries since 2010. Historically it has taken more than a decade for the first children in developing countries to access the same new, effective vaccines as children in richer countries. In this case, newly developed pneumococcal vaccines were provided to developing countries within a year.

The report concludes that “the introduction of pneumococcal conjugate vaccines through the AMC pilot has accelerated immunisation coverage against pneumococcal disease across 53 Gavi counties to date, with 49 million [children] fully immunised [against the disease]”. The report also confirms that manufacturers made decisions to expand capacity to serve Gavi countries’ requirements in response to the AMC and its supply agreements…